XENE
Xenon Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$59.69
−1.18%Aug 25, 2026, 07:55 UTC
BlackRock Inc. acquired a new minority stake in Xenon Pharmaceuticals Inc., buying 7,522,482 shares valued at approximately $454.06 million, representing about 7.78% ownership, as disclosed in a 13F filing.
Source:Aug 7, 2026, 05:24 UTC
Xenon Pharmaceuticals Inc. held its Q2 2026 earnings call on August 6, 2026.
Source: